Varda wins $48 million Air Force contract
Varda’s first capsule on the ground in Utah.
The U.S. Air Force last week awarded the reusable orbiting capsule company Varda a four-year $48 million contract for placing experimental hypersonic payloads on the capsule for testing during its re-entry through the atmosphere.
The four-year deal with AFRL [Air Force Research Laboratory], announced on Nov. 26, leverages Varda’s W-Series reentry capsules as platforms to test payloads at hypersonic speeds. The spacecraft are built on Rocket Lab’s Photon satellite bus,
…Varda’s next mission, W-2, is scheduled for early 2025. This mission is designed to showcase the Varda Hypersonic Testbed vehicle. The capsule will carry an AFRL-developed spectrometer payload named OSPREE (Optical Sensing of Plasmas in the Reentry Environment) to collect critical data during atmospheric descent.
Up until now Varda’s customers have been entirely focused on using the capsule to produce pharmaceuticals in weightlessness for sale back on Earth. This new contract provides it another and initially unexpected way to make money on the capsule’s capabilities.
Varda’s first capsule on the ground in Utah.
The U.S. Air Force last week awarded the reusable orbiting capsule company Varda a four-year $48 million contract for placing experimental hypersonic payloads on the capsule for testing during its re-entry through the atmosphere.
The four-year deal with AFRL [Air Force Research Laboratory], announced on Nov. 26, leverages Varda’s W-Series reentry capsules as platforms to test payloads at hypersonic speeds. The spacecraft are built on Rocket Lab’s Photon satellite bus,
…Varda’s next mission, W-2, is scheduled for early 2025. This mission is designed to showcase the Varda Hypersonic Testbed vehicle. The capsule will carry an AFRL-developed spectrometer payload named OSPREE (Optical Sensing of Plasmas in the Reentry Environment) to collect critical data during atmospheric descent.
Up until now Varda’s customers have been entirely focused on using the capsule to produce pharmaceuticals in weightlessness for sale back on Earth. This new contract provides it another and initially unexpected way to make money on the capsule’s capabilities.